December 19, 2024
Fresenius Kabi USA LLC has lost its arguments in Delaware federal court that claims in a pair of Heron Therapeutics patents for a nausea drug were invalid, keeping Fresenius' generic from entering the market for around a decade.
August 01, 2023
Fresenius Kabi USA LLC lost its argument in Delaware federal court that some claims in several Heron Therapeutics nausea drug patents that it is accused of infringing are invalid as indefinite.